At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Treatment of Parkinson’s Disease with Virtual Reality
In a recent article by Mahato et al. (2026), 250 individuals with Parkinson’s disease were assigned to either traditional physical therapy or virtual reality (VR)-based…
SPAN Q4 Meeting Reminder
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting next week, on October 28, 2026, from 8:00–9:00 pm ET….
Virginia Audiology Regulations Open for Public Comment
The Virginia Board of Audiology and Speech-Language Pathology published a proposed rule allowing for ABA certification to serve as an alternative pathway for audiology licensure….



